Citigroup’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-197,565
| Closed | -$2.21M | – | 5126 |
|
|
2017
Q3 | $2.21M | Buy |
197,565
+89,216
| +82% | +$999K | ﹤0.01% | 1432 |
|
|
2017
Q2 | $1.19M | Buy |
108,349
+38,727
| +56% | +$426K | ﹤0.01% | 1838 |
|
|
2017
Q1 | $682K | Sell |
69,622
-45,455
| -39% | -$445K | ﹤0.01% | 2223 |
|
|
2016
Q4 | $1.24M | Buy |
115,077
+65,701
| +133% | +$709K | ﹤0.01% | 2216 |
|
|
2016
Q3 | $506K | Buy |
49,376
+21,549
| +77% | +$221K | ﹤0.01% | 2425 |
|
|
2016
Q2 | $363K | Sell |
27,827
-22,464
| -45% | -$293K | ﹤0.01% | 2451 |
|
|
2016
Q1 | $553K | Buy |
50,291
+23,475
| +88% | +$258K | ﹤0.01% | 2606 |
|
|
2015
Q4 | $247K | Buy |
26,816
+22,070
| +465% | +$203K | ﹤0.01% | 2899 |
|
|
2015
Q3 | $33K | Sell |
4,746
-10,744
| -69% | -$74.7K | ﹤0.01% | 3779 |
|
|
2015
Q2 | $152K | Buy |
15,490
+4,189
| +37% | +$41.1K | ﹤0.01% | 2956 |
|
|
2015
Q1 | $100K | Sell |
11,301
-10,591
| -48% | -$93.7K | ﹤0.01% | 3405 |
|
|
2014
Q4 | $191K | Buy |
21,892
+17,671
| +419% | +$154K | ﹤0.01% | 3203 |
|
|
2014
Q3 | $29K | Sell |
4,221
-189
| -4% | -$1.3K | ﹤0.01% | 4041 |
|
|
2014
Q2 | $23K | Sell |
4,410
-12,010
| -73% | -$62.6K | ﹤0.01% | 4124 |
|
|
2014
Q1 | $75K | Sell |
16,420
-6,875
| -30% | -$31.4K | ﹤0.01% | 3712 |
|
|
2013
Q4 | $118K | Buy |
23,295
+8,716
| +60% | +$44.2K | ﹤0.01% | 3590 |
|
|
2013
Q3 | $73K | Sell |
14,579
-6,088
| -29% | -$30.5K | ﹤0.01% | 3379 |
|
|
2013
Q2 | $102K | Buy |
+20,667
| New | +$102K | ﹤0.01% | 3275 |
|